daclizumab monoclonal antibody drug. targets cd25 (alpha subunit of il-2 receptor on t-cells) and is used in treatment of multiple

antibody biological biosimilar biotech biotechnology cd25 daclizumab disease drug il2 immunoglobulin immunology infusion injection inn mab monoclonal ms multiple nomenclature peptide protein receptor rejection scleroris tcell transplant